Table 1 Baseline characteristics for patients with candida bloodstream infection (BSIs)
From: Antifungal resistance in patients with Candidaemia: a retrospective cohort study
Characteristics | Number of Patients (N = 189) n (%) |
|---|---|
Mean Age (years) | 57.3 ± 17.5 |
Gender | |
Male | 94 (49.74%) |
Female | 95 (50.26%) |
Bacteremia co-infection | 79 (41.8%) |
Baseline Comorbidities | |
Diabetes | 99 (52.38%) |
Hypertension | 105 (55.56%) |
Chronic kidney disease | 24 (12.7%) |
Liver Cirrhosis | 33 (17.46%) |
Cardiovascular diseases | 96 (50.79%) |
Lung diseases | 52 (27.51%) |
Human immunodeficiency virus | 3 (1.59%) |
Solid organ transplantation | 8 (4.23%) |
Hematological malignancy | 9 (4.76%) |
Non hematological malignancy | 48 (25.4%) |
Neutropenia a | 25 (13.23%) |
History of IV drug user | 3 (1.59%) |
Blood/ Platelet transfusion | 135 (71.43%) |
Recent hospital admission | 35 (18.52%) |
Exposure to medication within 3 months a | |
Broad spectrum antibiotics | 182 (96.3%) |
Polyene antifungal | 3(1.59%) |
Azole antifungal (Fluconazole) | 11 (5.82%) |
Echinocandins | 38 (20.11%) |
Corticosteroids | 86 (45.5%) |
Exposure to medical procedures within 3 months | |
TPN | 20 (10.58%) |
Central line insertion | 151 (79.89%) |
Urine catheter | 148 (78.31%) |
Invasive Ventilation | 100 (52.91%) |
Surgery within 3 months | 77 (40.74%) |
GI | 38 (49.35%) |
Non- GI | 39 (50.65%) |
Renal Replacement therapy | 66 (34.92%) |
HD | 54 (28.57%) |
PD | 4 (2.12%) |
CRRT | 11 (5.82%) |
SLID | 4 (2.12%) |